Convatec Group Plc (CTEC.L), a medical products and technologies company, said on Thursday it will unveil its new "Accelerate" strategy at its Capital Markets Day, outlining plans to drive the next phase of sustainable and profitable growth.
The group expects the Accelerate strategy to support its upgraded medium-term guidance, targeting annual organic revenue growth of 6% to 8%, with growth across all business segments. It also aims to achieve an adjusted operating margin of 24% to 26%, alongside double-digit annual growth in adjusted earnings per share.
The company said Accelerate builds on its previous FISBE strategy, which helped transform Convatec into a chronic care leader across its core categories, including advanced wound care, ostomy care, continence care and infusion care. The new strategy is aimed at scaling growth further, backed by what the company described as its strongest pipeline of innovation to date.
Convatec said the strategy is structured around four pillars: customer-focused growth, technology and innovation, execution excellence, and culture, purpose and performance. These initiatives are designed to deepen engagement with patients and healthcare professionals, expand market share, accelerate product development and enhance operational efficiency.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.